The study also confirmed that rapid decline in anti-envelope Ab titer occurs early during suppressive ART, but boosting of anti-Env Abs and FcγR binding activities was achieved after only a few STI cycles, even when viral rebound was low (e.g., 460 copies/mL). This evidence concerns the gene ERVW-1 and sexually transmitted disease.